Looking at Charles Bonnet Syndrome: Prevalence and Experiences of Patients Attending a Vision Rehabilitation Clinic

2018 ◽  
Vol 112 (5) ◽  
pp. 488-496 ◽  
Author(s):  
Lisa M. Ord ◽  
Amy Henderson ◽  
Robert M. Christiansen

Introduction The objective of this study was to determine the prevalence of Charles Bonnet syndrome in a population of patients seen in a vision rehabilitation clinic and to gain deeper insight into the content of visual hallucinations that are experienced. Methods This investigation was a retrospective review of medical record vision rehabilitation evaluations from 100 adult patients who were seen consecutively in a vision rehabilitation clinic. Data collected included age, gender, eye condition, current medications, other medical diagnoses, current living situation, and responses to questions about Charles Bonnet syndrome symptomatology. Results Eight participants were excluded from analysis due to diagnosis of cognitive impairment or a current anticholinergic medication. A total of 25.0% (n = 23) of eligible patients with visual impairments reported visual hallucinations that met the definition of Charles Bonnet syndrome. Images of people (35%) were the most common hallucinations reported by participants, followed by images of animals (26%). Discussion The occurrence of this syndrome in our study is near the mid-range of estimated prevalence in the professional literature. Implications for practitioners Individuals with this syndrome are hesitant to disclose that they are experiencing hallucinations for fear of being seen as having dementia or psychosis. An important concept for vision professionals, especially those offering visual rehabilitation, is integrating screening for Charles Bonnet syndrome into their care planning. Demonstrating that the syndrome is not a rare occurrence helps raise awareness of it in people with vision loss, thus explaining it as not so unusual and facilitating a discussion between patients and professionals that will reduce the apprehension that many individuals with visual impairments have that these hallucinations are a sign of more concerning conditions.

Author(s):  
Tsuyshi Miyaoka ◽  
Michiharu Nagahama ◽  
Keiko Tsuchie ◽  
Maiko Hayashida ◽  
Akira Nishida ◽  
...  

2011 ◽  
Vol 26 (S2) ◽  
pp. 378-379 ◽  
Author(s):  
H.C. Hsu ◽  
T.C. Chen ◽  
Y.S. Huang ◽  
W.X. Fan

BackgroundCBS becomes more prevalent as the population ages and the number of patients with low vision increases. Clinical features of CBS have been described as complex visual hallucinations with insight due to the vision loss or visual ability decrease in patients who’re otherwise mentally normal. We describe three typical CBS patients whose visual hallucinations developed after bilateral severe visual impairment due to diabetic retinopathy. They responded well to treatment with trazodone. The effectiveness of trazodone in these patients adds to evidence implicating serotonergic pathways in the pathogenesis of visual hallucinations.Case reportThe characteristics of 3 patients and their reactions are listed in table 1.DiscussionThis is the first report describing the effectiveness of trazodone in treating typical CBS patients. It indicates that trazodone is an safer option for the treatment of CBS, especially in the elderly, diabetic population. In addition to having fewer interactions with comedications, trazodone has fewer adverse effects and relative lower body weight gain risk compared to anticonvulsants and neuroleptics. CBS is a condition that many clinicians aren’t very familiar with, yet it’s a surprisingly high prevalence rate (10%-30%) among the visually impaired. Clinicians must therefore keep in mind and ask elderly people with visual impairment whether they’ve hallucinations.


2012 ◽  
Vol 25 (3) ◽  
pp. 505-506
Author(s):  
Kurt Segers

ABSTRACTA patient with a history of Parkinson's disease and severe bilateral peripheral vision loss due to vitreous hemorrhages had complex visual hallucinations that persisted for three days and appeared every morning on awakening. The persistent nature of these hallucinations, the patient's preserved insight, and the presence of severe visual impairment was suggestive for Charles Bonnet syndrome rather than Parkinson-related hallucinations. A treatment with carbamazepine was started and proved to be successful. Physicians treating Parkinson patients should be familiar with Charles Bonnet syndrome and consider it as a potential alternative etiology for visual hallucinations, especially when the patient has severely impaired vision and when the hallucinations are sustained during wakefulness.


2017 ◽  
Vol 41 (S1) ◽  
pp. S172-S172 ◽  
Author(s):  
H.C. Hsu ◽  
Y.S. Huang ◽  
W.X. Fan ◽  
T.C. Chen

BackgroundCBS becomes more prevalent as the population ages. CBS is characterized by the triad of impairment of vision, complex visual hallucinations with insight, mentally normal people. Although visual hallucinations in the elderly are often associated with dementia with Lewy body, Alzheimer's disease and delirium, they are excluded from the diagnosis of typical CBS. Here, we describe three typical CBS patients whose visual hallucinations developed after bilateral severe visual impairment due to diabetic retinopathy. The effectiveness of agomelatine adds to evidence implicating serotonergic and melatoninergic pathways in the pathogenesis of visual hallucinations.Case reportThe average age of these three patients (2 males and 1 female) is 71. Except for the visual hallucinations, all patients showed no psychiatric symptoms or cognitive decline or neurological focal signs. They were frequently upset by the fact of hallucinating, fearing that they are losing their minds. They lived in fear of impending insanity, guilty feeling, unhappy mood, insomnia. The frequency of visual hallucinations stopped with agomelatine 25 mg/day for 3 weeks in these cases.DiscussionTo our knowledge, this is the first report describing the effectiveness of agomelatine in treating typical CBS patients and indicates that agomelatine is an safer option for the treatment of CBS, especially in the elderly, diabetic population. Therapeutic options for CBS still remain poor and of uncertain benefit for the individual patient. CBS has a high prevalence rate (0.4%–30%) among the visually impaired. Clinicians must ask elderly people with visual impairment whether they have hallucinations. Firm reassurance that the syndrome is not related to mental illness is a major relief to an elderly person burdened already with failing vision.Disclosure of interestThe authors have not supplied their declaration of competing interest.


Sign in / Sign up

Export Citation Format

Share Document